Menu
Search

Tag: Tempest Therapeutics

Browse exclusive Tags!

Tempest Therapeutics Grants Employee Nonqualified Stock Option for 7,650 Shares, Accelerating Vesting over Four Years, US

0
Tempest Therapeutics grants employee nonqualified stock option for 7,650 shares, aligning long-term interests and fostering innovation in oncology research.

Tempest Therapeutics Appoints Sam Whiting, M.D. Ph.D., as Head of R&D, US

0
Tempest Therapeutics welcomes Dr. Sam Whiting as Head of R&D, advancing cancer treatment through targeted and immune-mediated therapies. Learn more now.

Popular

Tempest Therapeutics Grants Employee Nonqualified Stock Option for 7,650 Shares, Accelerating Vesting over Four Years, US

Business 0
Tempest Therapeutics grants employee nonqualified stock option for 7,650 shares, aligning long-term interests and fostering innovation in oncology research.

Subscribe

spot_imgspot_img

About us

Welcome to The Reportify Media Limited, your trusted source for comprehensive and reliable news reports. We are dedicated to bringing you the latest updates and insightful analysis on global events, politics, business, technology, and more. Stay informed and engaged with our well-researched articles, in-depth features, and thought-provoking perspectives. Join our community of informed readers as we navigate the complex world of news together.

Company

The latest

Revolutionary Small Business Exchange Network Connects Sellers and Buyers

Business 0
Revolutionary SBEN connects small business sellers and buyers, transforming the way businesses are bought and sold in the U.S.

District 1 Commissioner Race Results Delayed by Recounts & Ballot Reviews, US

Politics 0
District 1 Commissioner Race in Orange County faces delays with recounts and ballot reviews. Find out who will come out on top in this close election.

Fed Minutes Hint at Potential Rate Cut in September amid Economic Uncertainty, US

General 0
Federal Reserve minutes suggest potential rate cut in September amid economic uncertainty. Find out more about the upcoming policy decisions.

Subscribe

© 2023 The Reportify Media Limited. All Rights Reserved.